drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy




























































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   
























































































































































































































































Week of Mon, Oct 14th, 2013

CCA Industries appoints new CEO

Richard Kornhauser has been named as the new president and chief executive officer of CCA Industries Inc.

Prasco, Shire sign pact for Fosrenol generic

Prasco Laboratories has entered an exclusive U.S. distribution and supply agreement with Shire for the authorized generic of Fosrenol Chewable Tablets.

UrgentRx lands retail distribution at CVS

UrgentRx has expanded retail distribution for its line of fast-acting, over-the-counter powder medicines to CVS/pharmacy, OfficeMax and airport retailer Paradies Stores.

Katy Perry becomes new CoverGirl

Music star Katy Perry has been named as the latest CoverGirl.

Private equity firm to buy McKesson Automation

Francisco Partners, a technology-focused private equity firm, plans to acquire McKesson Automation, a unit of McKesson Corp. that provides integrated pharmacy automation solutions to hospitals and health systems.

Former FDA chief joins Johnson & Johnson board

Mark McClellan, a former commissioner of the Food and Drug Administration, has joined the board of directors of Johnson & Johnson.

Teva slated to launch generic TOBI

Teva Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for tobramycin inhalation solution in the United States.

VIVUS, Auxilium enter marketing, supply pacts for Stendra

VIVUS Inc. has signed an agreement giving Auxilium Pharmaceuticals Inc. the exclusive rights to market its erectile dysfunction (ED) drug Stendra in the United States and Canada.

Advertisement